Chrissy is an associate in Economist Impact's health policy and clinical evidence team. Chrissy’s current role involves rapid reviews of scientific papers underlying health news reports, critical appraisal of scientific papers for audiences such as NHS commissioners, and the European Food Information Council. Chrissy also designs and works on longer-term research assignments across the health market from industry to academia, regulators and payers, bringing specialist methods in epidemiological and economic modelling.
Chrissy has an undergraduate degree in Occupational Therapy from York St John University, and two MSc degrees. The first MSc in Professional Health and Social Care from York St John University and the second in Epidemiology and Biostatistics from the University of Leeds. Chrissy was awarded a National Institute for Health Research scholarship to pursue a doctorate investigating the healthcare needs of children with chronic conditions in multi-ethnic communities. She received her doctorate in March 2019 from the University of Bradford. Chrissy worked as a Senior Occupational Therapist in the NHS and an Operations Manager for a private health care company before joining the Health Policy and Clinical Evidence team.
Steven Cramer, Professor of Neurology at the University of California, Los Angeles, discusses gaps and opportunities around stroke in the US.
Dr. Muthoni Gichu, head of the Health and Ageing Unit at the Ministry of Health, Kenya, highlights the landscape of neurological disorders in Kenya, including epilepsy.
Frédéric Destrebecq, Executive Director at European Brain Council, lays out the impact and need for policy action on brain disorders in Europe.
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
